Introduction Guangdong Xiangxue Precision Medical Technology Co., Ltd. specializes in the development of cancer treatments using TCR-based therapies. The company offers a range of services including large scale GMP grade lentivirus production, target identification and lead optimization, efficacy validation and safety testing in cell lines and animal models, clinical trial development, and market entry planning. Founded in November 12, 2015, the company is headquartered in Guangzhou, China. |